Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Vaccine symbols : Sny save search
Pneumococcal Vaccine Market, 41% of Growth to Originate from North America, Technavio
Published: 2024-04-16 (Crawled : 22:00) - prnewswire.com
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: 0.12%
H: 0.51%
C: 0.51%
SNY | News | $46.34 2.09% 620K
|
Health Technology
|
| O: 1.05%
H: 0.0%
C: 0.0%
pneumococcal vaccine growth
Moderna Advances Multiple Vaccine Programs to Late-Stage Clinical Trials
Published: 2024-03-27 (Crawled : 12:00) - biospace.com/
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: -0.26%
H: 0.0%
C: 0.0%
SNY | News | $46.34 2.09% 620K
|
Health Technology
|
| O: 1.06%
H: 0.0%
C: 0.0%
MRNA S | $102.68 0.67% 640K
|
Health Technology
|
| O: 2.02%
H: 1.41%
C: 0.92%
vaccine trials
World Vaccine Market Research Report 2023-2024 and 2030 - Increasing Consumer Awareness Towards Immunization Fueling Growth Amid Growing Prevalence of Infectious Diseases
Published: 2024-03-12 (Crawled : 02:00) - prnewswire.com
SNY | News | $46.34 2.09% 620K
|
Health Technology
|
| O: 0.01%
H: 0.0%
C: 0.0%
report vaccine world research growing growth market
Vaccine research market size to grow at a CAGR of 9.88% from 2022 to 2027, Abbott Laboratories, Astellas Pharma Inc., AstraZeneca Plc, more to emerge as key players, Technavio
Published: 2024-03-11 (Crawled : 14:30) - prnewswire.com
CMXHF | $172.54 50
|
n/a
|
| O: 0.41%
H: 0.0%
C: 0.0%
CSLLY | $86.918 60K
|
n/a
|
| O: -4.92%
H: 3.76%
C: 3.44%
GLAXF | $20.2 510
|
Health Technology
|
| O: -3.4%
H: 1.49%
C: 1.49%
AZNCF | $138.24 800
|
Health Technology
|
| O: 1.55%
H: 0.82%
C: 0.16%
ALPMY | $9.47 520K
|
Manufacturing
|
| O: -1.41%
H: 5.06%
C: 4.01%
GSK | $39.685 1.06% 380K
|
Health Technology
|
| O: -0.6%
H: 0.19%
C: 0.09%
ABT | News | $107.24 1.87% 2M
|
Health Technology
|
| O: 0.26%
H: 0.0%
C: 0.0%
SNY | News | $46.34 2.09% 620K
|
Health Technology
|
| O: 0.57%
H: 0.0%
C: 0.0%
AZN | $68.545 0.27% 1.2M
|
Health Technology
|
| O: 1.08%
H: 0.82%
C: 0.67%
pharma vaccine astrazeneca research key market
Global Respiratory Disease Vaccine Market Set for Growth, Fueled by Aging Populations and Vaccine Mandates - Trends, Opportunities, and Forecasts, 2018-2028F
Published: 2024-01-22 (Crawled : 17:00) - prnewswire.com
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: 1.71%
H: 0.0%
C: -0.15%
AZNCF | $138.24 800
|
Health Technology
|
| O: 2.63%
H: 0.8%
C: 0.75%
JNJ | News | $146.39 0.45% 1.8M
|
Health Technology
|
| O: 0.6%
H: 0.0%
C: 0.0%
SNY | News | $46.34 2.09% 620K
|
Health Technology
|
| O: -0.21%
H: 0.0%
C: 0.0%
AZN | $68.545 0.27% 1.2M
|
Health Technology
|
| O: 1.8%
H: 0.14%
C: -0.89%
disease vaccine respiratory global set market
Fluzone High-Dose Quadrivalent vaccine remains preferentially recommended to protect adults 65 years of age and older against influenza
Published: 2024-01-03 (Crawled : 22:00) - biospace.com/
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: 0.49%
H: 0.0%
C: -0.26%
SNY | News | $46.34 2.09% 620K
|
Health Technology
|
| O: 1.38%
H: 0.0%
C: 0.0%
vaccine influenza
BioNTech Achieves Milestone at mRNA-based Vaccine Manufacturing Site in Rwanda
Published: 2023-12-18 (Crawled : 18:00) - globenewswire.com
SNY | News | $46.34 2.09% 620K
|
Health Technology
|
| O: 0.45%
H: 0.0%
C: 0.0%
BNTX | $87.02 0.99% 140K
|
Health Technology
|
| O: 0.9%
H: 2.47%
C: 2.11%
vaccine milestone
Influenza Vaccine Market to grow by USD 2.93 billion from 2022 to 2027; North America to account for 54% of market growth - Technavio
Published: 2023-12-13 (Crawled : 19:00) - prnewswire.com
CMXHF | $172.54 50
|
n/a
|
| O: 5.56%
H: 0.71%
C: 0.71%
CSLLY | $86.918 60K
|
n/a
|
| O: 1.46%
H: 3.01%
C: 0.97%
GLAXF | $20.2 510
|
Health Technology
|
| O: 0.58%
H: 0.0%
C: -1.01%
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: 0.25%
H: 0.0%
C: 0.0%
AZNCF | $138.24 800
|
Health Technology
|
| O: 1.19%
H: 3.09%
C: 1.3%
GSK | $39.685 1.06% 380K
|
Health Technology
|
| O: 0.76%
H: 1.0%
C: -0.11%
BAX | $39.945 0.74% 430K
|
Health Technology
|
| O: 1.7%
H: 2.44%
C: 1.78%
SNY | News | $46.34 2.09% 620K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
AZN | $68.545 0.27% 1.2M
|
Health Technology
|
| O: 1.21%
H: 0.27%
C: -0.52%
america vaccine influenza growth market
GSK Pulls Ahead of Pfizer in RSV Vaccine Market as Arexvy Nears Blockbuster S...
Published: 2023-12-01 (Crawled : 14:30) - biospace.com/
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: 1.39%
H: 0.0%
C: -0.05%
SNY | News | $46.34 2.09% 620K
|
Health Technology
|
| O: 0.93%
H: 0.0%
C: 0.0%
vaccine rsv market
GSK Pulls Ahead of Pfizer in RSV Vaccine Market as Arexvy Nears Blockbuster Status
Published: 2023-12-01 (Crawled : 13:30) - biospace.com/
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: 1.39%
H: 0.0%
C: -0.05%
SNY | News | $46.34 2.09% 620K
|
Health Technology
|
| O: 0.93%
H: 0.0%
C: 0.0%
vaccine rsv market
Rabies Vaccine Market to Reach $ 1903.17 million by 2032, exhibiting a CAGR of 4.7% from 2023 to 2032: Allied Market Research
Published: 2023-11-25 (Crawled : 08:20) - prnewswire.com
SNY | News | $46.34 2.09% 620K
|
Health Technology
| Email alert
Add to watchlist
ELAN | $13.335 -1.73% 940K
|
Process Industries
| Email alert
Add to watchlist
SNYNF | News | $92.7 600K
|
Health Technology
| Email alert
Add to watchlist
NVS | $93.815 1.35% 410K
|
Health Technology
| Email alert
Add to watchlist
NVSEF | $93.6375 6.88% 82K
|
Health Technology
| Email alert
Add to watchlist
ZTS | News | $148.65 -2.91% 1.6M
|
Health Technology
| Email alert
Add to watchlist
FNCTF | News | $11.0354 320
|
Communications
| Email alert
Add to watchlist
vaccine reach research market
HDT Bio to Participate in World Vaccine Congress West Coast 2023
Published: 2023-11-16 (Crawled : 15:00) - biospace.com/
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: 3.37%
H: 1.29%
C: 1.29%
SNY | News | $46.34 2.09% 620K
|
Health Technology
|
| O: 1.54%
H: 0.0%
C: 0.0%
west vaccine congress world
Global HBV Vaccine Market Set to Reach $2.47 Billion by 2023, Driven by Rising HBV Cases Among Infants
Published: 2023-11-11 (Crawled : 04:20) - prnewswire.com
SNY | News | $46.34 2.09% 620K
|
Health Technology
| Email alert
Add to watchlist
DVAX | $11.59 2.21% 490K
|
Health Technology
| Email alert
Add to watchlist
SNYNF | News | $92.7 600K
|
Health Technology
| Email alert
Add to watchlist
vaccine reach global set market
Pfizer and BioNTech Announce Positive Topline Data for mRNA-based Combination Vaccine Program Against Influenza and COVID-19
Published: 2023-10-26 (Crawled : 11:00) - globenewswire.com
PFE A | $25.615 0.89% 9.9M
|
Health Technology
|
| O: -0.39%
H: 2.48%
C: 1.8%
SNY | News | $46.34 2.09% 620K
|
Health Technology
|
| O: 0.09%
H: 0.0%
C: 0.0%
BNTX | $87.02 0.99% 140K
|
Health Technology
|
| O: 0.99%
H: 1.81%
C: 0.47%
covid-19 vaccine positive influenza topline program
MinervaX Raises EUR 54M in Upsized Financing to Advance the Development of its Maternal Vaccine Against Group B Streptococcus
Published: 2023-10-11 (Crawled : 07:00) - prnewswire.com
SNY | News | $46.34 2.09% 620K
|
Health Technology
|
| O: 1.1%
H: 0.0%
C: 0.0%
vaccine group
Global Influenza Vaccine Market Research Report 2023-2028: Shift in Trends towards mRNA-based Flu Vaccine Gaining Momentum
Published: 2023-10-05 (Crawled : 23:00) - prnewswire.com
GLAXF | $20.2 510
|
Health Technology
|
| O: 0.5%
H: 0.0%
C: 0.0%
AZNCF | $138.24 800
|
Health Technology
|
| O: -0.48%
H: 1.63%
C: -0.57%
GSK | $39.685 1.06% 380K
|
Health Technology
|
| O: 0.94%
H: 0.82%
C: 0.41%
SNY | News | $46.34 2.09% 620K
|
Health Technology
|
| O: -0.19%
H: 0.0%
C: 0.0%
AZN | $68.545 0.27% 1.2M
|
Health Technology
|
| O: 0.24%
H: 0.78%
C: 0.57%
report vaccine momentum influenza research global trends market
FDA Panel Sets Possible Precedent; Novavax Wins Approval for Updated COVID-19 Vaccine
Published: 2023-10-05 (Crawled : 15:30) - biospace.com/
PRGO | $30.22 0.94% 140K
|
Health Technology
|
| O: 0.4%
H: 2.05%
C: 1.82%
JNJ | News | $146.39 0.45% 1.8M
|
Health Technology
|
| O: 0.4%
H: 0.0%
C: 0.0%
SNY | News | $46.34 2.09% 620K
|
Health Technology
|
| O: 0.19%
H: 0.0%
C: 0.0%
covid-19 fda vaccine approval
Moderna Announces Positive Phase 1/2 Data from mRNA-1083, the Company's Combination Vaccine Against Influenza and COVID-19
Published: 2023-10-04 (Crawled : 12:00) - biospace.com/
SNY | News | $46.34 2.09% 620K
|
Health Technology
|
| O: 1.07%
H: 0.0%
C: 0.0%
MRNA S | $102.68 0.67% 640K
|
Health Technology
|
| O: 1.48%
H: 0.2%
C: -0.33%
rna-1083 covid-19 vaccine positive influenza
Press Release: Sanofi announces agreement for potential first-in-class vaccine against extraintestinal pathogenic E. coli
Published: 2023-10-03 (Crawled : 06:00) - globenewswire.com
JNJ | News | $146.39 0.45% 1.8M
|
Health Technology
|
| O: -0.26%
H: 0.53%
C: 0.43%
SNY | News | $46.34 2.09% 620K
|
Health Technology
|
| O: -1.41%
H: 0.0%
C: 0.0%
vaccine potential agreement sanofi
Pfizer and BioNTech Receive Health Canada Authorization for XBB.1.5-Adapted Monovalent COVID-19 Vaccine
Published: 2023-09-28 (Crawled : 17:00) - globenewswire.com
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: -2.28%
H: 0.0%
C: -0.06%
SNY | News | $46.34 2.09% 620K
|
Health Technology
|
| O: -1.61%
H: 0.0%
C: 0.0%
BNTX | $87.02 0.99% 140K
|
Health Technology
|
| O: 0.21%
H: 0.04%
C: -1.27%
covid-19 vaccine health authorization canada
Gainers vs Losers
| 79% | 21% |
Top 10 Gainers
AGBA | News | $1.22 205.0% 86M
|
Finance
EGOX | $0.0606 68.33% 250M
|
NVFY | $3.45 63.51% 20M
|
Consumer Durables
ZCMD | $1.98 36.55% 27M
|
Commercial Services
CHRO | $1.66 35.51% 70K
|
n/a
INDO | $5.43 33.09% 10M
|
Energy Minerals
PAPL | $2.07 26.22% 550K
|
RWOD | $10.08 26.05% 5.6M
|
n/a
AULT | $0.304 25.57% 47M
|
Manufacturing
HUSA 4 | $2.07 23.95% 2.1M
|
Energy Minerals
Your saved searches
Save your searches and get alerts when important news are released.